Drug cuts breast cancer by half in high-risk women
53% less risk of cancer in post-menopausal women who took drugRelated items from OnMedicaData don’t support HRT for chronic disease preventionBenefit of Herceptin in more breast cancer casesBreast cancer rate falls with decline in HRT useEarly HRT may raise cancer riskPros of Herceptin outweigh cons for breast cancer, finds study
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Herceptin | Men | Menopause | Study | UK Health | Women